Skip to main content
. 2017 Jul 24;190(1):19–28. doi: 10.1111/cei.13004

Figure 1.

Figure 1

Nucleoprotein (NP)‐specific antibody responses after NP wild‐type (NPwt) protein (with or without Matrix‐M™ adjuvant) or recombinant Modified Vaccinia virus Ankara (rMVA)–NPwt vaccination. The immunoglobulin (Ig)G1 and IgG2a NP‐specific antibody responses 21 days after the primary vaccination (a,b) or 14 days after the booster vaccination (c,d). IgG1 (a,c) or IgG2a (b,d) serum antibodies were detected using purified NPwt protein and anti‐IgG1 or anti‐IgG2a horseradish peroxidase (HRP)‐conjugated antibodies. Mean of each group is indicated. MM = Matrix‐M™ adjuvant. ****P < 0·0001.